PTGX gets U.S. FDA approval for rusfertide in Polycythemia Vera
Protagonist Therapeutics said the U.S. FDA approved MIMRYLO (rusfertide) for Polycythemia Vera.
Story updates
12:30:07 AM UTC
SquawkNews
Protagonist Therapeutics Announces U.S. FDA Approval of Hepcidin Mimetic Peptide MIMRYLO(TM) (rusfertide) for Polycythemia Vera
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.